Handb Exp Pharmacol. 2026 May 12. doi: 10.1007/164_2026_800. Online ahead of print.
ABSTRACT
Metabolic syndrome (MetS) encompasses an interconnected set of risk factors, including abdominal obesity, insulin resistance, hypertension, dyslipidemia, and systemic inflammation, all of which significantly increase the risk of cardiovascular diseases (CVDs). This chapter provides an overview of animal models used to study cardiovascular complications associated with MetS. We examine commonly used models, including monogenic and polygenic rodent strains, diet-induced and chemically induced models, and large-animal systems, and discuss their strengths and limitations. The chapter then explores cardiac and vascular alterations in MetS and translation to humans. By integrating findings from diverse experimental models with human clinical data, the chapter aims to advance understanding of research on MetS-associated cardiovascular complications.
PMID:42113221 | DOI:10.1007/164_2026_800